Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Influenza A Virus (IAV) Nucleoprotein Monoclonal Antibody-[HRP]

Product Overview

BioVenic mouse monoclonal antibody is specific for influenza A virus nucleoprotein. It can be applied to ELISA and WB of influenza A virus nucleoprotein.

Specifications

Application ELISA; WB

Clonality Monoclonal

Classification Primary Antibody

Clone L13N22

Host Mouse

Target Species Virus

Species Reactivity Virus

Specificity Influenza A Virus Nucleoprotein

Isotype IgG1

Purity > 90%

Conjugation HRP

Buffer Stock Solution in 50% Glycerol/50% Phosphate Buffered Saline, pH 7.4

Physical State Liquid

Target Information

The influenza A virus nucleoprotein (NP) is a vital component of the virus, playing a crucial role in the packaging and replication of the viral genome. As a target for antiviral therapy, NP is a highly conserved protein among different strains of influenza A, making it an attractive candidate for broad-spectrum treatments. It is involved in multiple stages of the virus life cycle, including the assembly of viral ribonucleoprotein complexes and the protection of viral RNA from host defenses. The NP's structure is well-characterized, featuring an elongated shape with multiple domains that facilitate its interactions with other viral and host proteins.

Target Influenza A Virus Nucleoprotein

Target Synonym NP

Taxonomy ID 11320

Shipping and Storage

This product is shipped at ambient temperature. Store at 4°C (up to 12 months) on receipt. Do not freeze.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Szeto, Wun-Chung, et al. "Interaction between influenza A virus nucleoprotein and PB2 cap-binding domain is mediated by RNA." Plos one 15.9 (2020): e0239899.